Abstract
Bacitracin is produced by strains of Bacillus licheniformis. The commercial product contains a main component, bacitracin A (Fig. 1), and at least nine additional closely related polypeptides (Regna, 1959). In neutral or slightly alkaline solution, bacitracin A is slowly transformed into bacitracin F (Fig. 2) (Regna, 1959) which has very little antibacterial activity (Hickey, 1964).
Keywords
- Antibacterial Action
- Minimal Inhibitory Concentration
- Stability Constant
- Bacillus Licheniformis
- Cell Wall Synthesis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraha., E. P., and G. G. F. Newto.: Structure and function of some sulfur containing peptides. In: Cib. foundation symposium on amino acids and peptides with antimetabolic activity, p. 205. London: J. & A. Churchill Ltd. 1958.
Adle., R. H., and J. E. Snok.: Requirement of divalent metal ions for bacitracin activity. J. Bacteriol. 83, 1315 (1962).
Alber., A.: Metal-binding agents in chemotherapy: the activation of metals by chelation. In: The strategy of chemotherapy, p. 112. Cambridge: Cambridge University Press 1958.
Anderso., J. S., M. Matsuhash., M. A. Haski., and J. L. Strominge.: Lipidphosphoacetylmuramylpentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proc. Natl. Acad. Sci. U.S. 5., 881 (1965).
Anke., H. S., B. A. Johnso., J. Goldber., and F. L. Melene.: Bacitracin: methods of production, concentration, and partial purification, with a summary of the chemical properties of crude bacitracin. J. Bacteriol. 5., 249 (1948).
Bar., L. N., R. F. Wisema., and O. J. Abbot.: Levels of antibiotics in the intestinal tract of chicks fed bacitracin and penicillin. Poultry Sci. 4., 489 (1965).
Broc., T. D.: Effect of antibiotics and inhibitors on M protein synthesis. J. Bacteriol. 8., 527 (1963).
Chornoc., F. W.: Zinc bacitracin feed supplement. U.S. Patent., 809, 892 (1957).
Crease., E. H.: The induced (adaptive) biosynthesis of β-galactosidase in Staphylococcus aureu.. J. Gen. Microbiol. 1., 288 (1955).
Foy., W. A.: Role of metal-binding in the biological activities of drugs. J. Pharmaceut. Sci. 5., 93 (1961).
Gal., E. F., and J. P. Folke.: The assimilation of amino acids by bacteria. 15. Actions of antibiotics on nucleic acid and protein synthesis in Staphylococcus aureu.. Biochem. J. 5., 493 (1953).
Gal., E. F., and J. P. Folke.: The assimilation of amino acids by bacteria. 21. The effect of nucleic acids on the development of certain enzymatic activities in disrupted staphylococcal cells. Biochem. J. 5., 675 (1955).
Garbut., J. T., A. L. Morehous., and A. M. Hanso.: Metal binding properties of bacitracin. J. Agr. Food Chem., 285 (1961).
Gezo., H. M., D. M. Fasa., and G. R. Collin.: Antibiotic studies on beta hemolytic streptococci. Vi.. Acquired in vitro resistance to bacitracin. Proc. Soc. Exptl. Biol. Med. 7., 505 (1950).
Gros., H. M.: Zinc bacitracin in pharmaceutical preparations. Drug & Cosmetic Ind. 7., 612 (1954).
Hancoc., R., and P. C. Fitz-Jame.: Some differences in the action of penicillin, bacitracin, and vancomycin on Bacillus megateriu.. J. Bacteriol. 8., 1044 (1964).
Helm., V., and E. D. Weinber.: Mechanism of antibacterial action of N1,N5-di(3,4-dichlorobenzyl)-biguanide. In: Antimicrobial Agents and Chemotherapy 1962, p. 241. Ann Arbor (Mich.): Amer. Soc. Microbiol. 1963.
Hicke., R. J.: Bacitracin, its manufacture and uses. Progr. Ind. Microbiol., 95 (1964).
Hinto., N. A., and J. H. Or.: The effect of antibiotics on the toxin production of Staphylococcus aureu.. Antibiotics & Chemotherapy 1., 758 (1960).
Hodg., E. B., and G. J. Laffert.: Zinc bacitracin-containing troche. U.S. Patent 2,803, 584 (1957).
Jawet., E.: Polymyxin, colistin, and bacitracin. Pediat. Clin. North Am., 1057 (1961).
Krawit., E. L., and J. R. War.: L phase variants related to antibiotic inhibition of cell wall biosynthesis. Proc. Soc. Exptl. Biol. Med. 11., 629 (1963).
Lowbur., E. J. L.: Clinical problems of drug-resistant pathogens. Brit. Med. Bull. 1., 73 (1960).
Mandelsta., J., and H. J. Roger.: The incorporation of amino acids into the cell-wall mucopeptide of staphylococci and the effect of antibiotics on the process. Biochem. 72, 654 (1959).
Maxte., W. R.: The use of bacitracin for identifying group A haemolytic streptococci. J. Clin. Pathol., 224 (1953).
Molande., C. W., B. M. Kaga., H. J. Weinberge., E. M. Heimlic., and R. J. Busse.: Induction by antibiotics and comparative sensitivity of L-phase variants of Staphylococcus aureu.. J. Bacteriol. 8., 591 (1964).
Par., J. T.: Inhibition of synthesis of bacterial mucopeptide or protein by certain antibiotics and its possible significance for microbiology and medicine. In: Antimicrobial Agents Ann. 1960, p. 338. New York: Plenum Press 1961.
Petra., E. I.: Comparison of the fluorescent antibody and the bacitracin disk methods for identification of group A streptococci. Amer. J. Clin. Pathol. 4., 224 (1961).
Regn., P. P.: The chemistry of antibiotics. In: Antibiotics; their chemistry and nonmedical uses, p. 58. New York: D. van Nostrand Co., Inc. 1959.
Rott., J., W. W. Karakaw., and R. M. Kraus.: Isolation of L forms from group A streptococci exposed to bacitracin. J. Bacteriol. 8., 1581 (1965).
Schroede., H. A., and J. J. Balass.: Abnormal trace metals in man cadmium. J. Chronic Diseases 1., 236 (1961).
Shar., V. E., A. Arriagad., G. G. F. Newto., and E. P. Abraha.: Ayfivin: extraction, purification, and chemical properties. Brit. J. Exptl. Pathol. 3., 444 (1949).
Shockma., G. D., and J. O. Lampe.: Inhibition by antibiotics of the growth of bacterial and yeast protoplasts. J. Bacteriol. 8., 508 (1962).
Smit., J. L., and E. D. Weinber.: Mechanisms of antibacterial action of bacitracin. J. Gen. Microbiol. 2., 559 (1962).
Snok., J. E., and N. Cornel.: Protoplast lysis and inhibition of growth of Bacillus licheniformi. by bacitracin. J. Bacteriol. 8., 415 (1965).
Ston., J. L.: Induced resistance to bacitracin in cultures of Staphylococcus aureu.. J. Infectious Diseases 8., 91 (1949).
Szybalsk., W., and V. Bryso.: Genetic studies on microbial cross resistance to toxic agents. 1. Cross resistance of Escherichia col. to fifteen antibiotics. I. Bacteriol. 6., 489 (1952).
Tipto., I. H., and M. J. Coo.: Trace elements in human tissue. Part II. Adult subjects from the United States. Health Physics., 103 (1963).
Tipto., I. H., H. A. Schroede., H. M. Perr. jr., and M. J. Coo.: Trace elements in human tissue. Part Ii.. Subjects from Africa, the Near and Far East, and Europe. Health Physics 1., 403 (1965).
Vohr., P., and F. H. Kratze.: Influence of various chelating agents on the availability of zinc. J. Nutrition 8., 249 (1964).
War., J. R., S. Madof., and L. Diene.: In vitro sensitivity of some bacteria, their L forms and pleuropneumonia-like organisms to antibiotics. Proc. Soc. Exptl. Biol. Med. 9., 132 (1958).
Weinber., E. D.: The mutual effects of antimicrobial compounds and metallic cations Bacteriol. Rev. 2., 46 (1957).
Weinber., E. D.: Enhancement of bacitracin by the metallic ions of group Ii.. In: Antibiotics Annual 1958/59, 924. New York (N.Y.): Medical Encyclopedia, Inc. 1959.
Weinber., E. D.: Known and suspected roles of metal coordination in actions of antimicrobial drugs. Federation Proc. 2. (Suppl. 10), 132 (1961).
Weinber., E. D.: Antibacterial action of polyamines in presence of trace metals: enhancement by cadmium. In: Antimicrobial Agents and Chemotherapy 1963, 573. Ann Arbor (Mich.): Amer. Soc. Microbiol. 1964.
Weinber., E. D.: Microbiological method for estimation of stability constants of bacitracin complexes of zinc, cadmium, and manganese. In: Antimicrobial Agents and Chemotherapy 1964, 120. Ann Arbor (Mich.): Amer. Soc. Microbiol. 1965.
William., R. E. O.: L forms of Staphylococcus aureu.. J. Gen. Microbiol. 3., 325 (1963).
Wis., E. M., and J. T. Par.: Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. Proc. Natl. Acad. Sci. U.S. 5., 75 (1965).
Ziffe., J., and T. J. Cairne.: Bacitracin composition as feed additive. U.S. Patent 3,025, 216 (1962).
Zin., E., and F. W. Chornoc.: Production of bacitracin. U.S. Patent 2,834, 711 (1958).
Zor., R. A.: Stabilization of bacitracin. U.S. Patent 2,903, 357 (1959).
Zor., R. A.: Bacitracin product. U.S. Patent 3,021, 217 (1962).
Zor., R. A., R. C. Malzah., and A. M. Hanso.: Bacitracin. U.S. Patent 2,985, 534 (1961).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Weinberg, E.D. (1967). Bacitracin. In: Gottlieb, D., Shaw, P.D. (eds) Antibiotics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-38439-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-38439-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37649-2
Online ISBN: 978-3-662-38439-8
eBook Packages: Springer Book Archive